Polly A. Murphy
CIK: 0001829248
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
37.7K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
26.7K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
Exercise(M)Direct29.6K shares- - Jun 10, 2026CELC
Celcuity Inc.
Gift(G)IndirectStock Option (right to buy)
14K shares- - Jun 10, 2026CELC
Celcuity Inc.
Gift(G)DirectStock Option (right to buy)
14K shares- - Jun 5, 2026CELC
Celcuity Inc.
Award(A)Direct1.5K shares- - May 18, 2026AVIR
Atea Pharmaceuticals, Inc.
Purchase(P)Direct6.1K shares at avg. $4.17$25K - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
Exercise(M)Direct29.6K shares- - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
29.6K shares- - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
41.2K shares- - May 28, 2025CELC
Celcuity Inc.
Gift(G)DirectStock Option (right to buy)
8.2K shares- - May 28, 2025CELC
Celcuity Inc.
Gift(G)IndirectStock Option (right to buy)
8.2K shares- - May 19, 2025CELC
Celcuity Inc.
Award(A)DirectStock Option (right to buy)
14K shares- - May 18, 2025AVIR
Atea Pharmaceuticals, Inc.
Purchase(P)Direct6.1K shares at avg. $4.17$25K - Jun 24, 2024CELC
Celcuity Inc.
Gift(G)DirectStock Option (right to buy)
11.6K shares- - Jun 24, 2024CELC
Celcuity Inc.
Gift(G)IndirectStock Option (right to buy)
11.6K shares- - Jun 24, 2024CELC
Celcuity Inc.
Gift(G)IndirectStock Option (right to buy)
16.3K shares- - Jun 24, 2024CELC
Celcuity Inc.
Gift(G)DirectStock Option (right to buy)
16.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AVIR Atea Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 37,700 | - | - | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 26,700 | - | - | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise(M) | 29,600 | - | $0 | Direct |
| Jun 10, 2026 |  CELC Celcuity Inc. | Gift(G) Stock Option (right to buy) | 14,048 | - | - | Indirect |
| Jun 10, 2026 | CELC Celcuity Inc. | Gift(G) Stock Option (right to buy) | 14,048 | - | - | Direct |
| Jun 5, 2026 | CELC Celcuity Inc. | Award(A) | 1,530 | - | $0 | Direct |
| May 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Purchase(P) | 6,100 | $4.17 | $25,446 | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Exercise(M) | 29,600 | - | - | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 29,600 | - | - | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 41,200 | - | - | Direct |
| May 28, 2025 | CELC Celcuity Inc. | Gift(G) Stock Option (right to buy) | 8,153 | - | - | Direct |
| May 28, 2025 | CELC Celcuity Inc. | Gift(G) Stock Option (right to buy) | 8,153 | - | - | Indirect |
| May 19, 2025 | CELC Celcuity Inc. | Award(A) Stock Option (right to buy) | 14,048 | - | - | Direct |
| May 18, 2025 | AVIR Atea Pharmaceuticals, Inc. | Purchase(P) | 6,100 | $4.17 | $25,446 | Direct |
| Jun 24, 2024 | CELC Celcuity Inc. | Gift(G) Stock Option (right to buy) | 11,645 | - | - | Direct |
| Jun 24, 2024 | CELC Celcuity Inc. | Gift(G) Stock Option (right to buy) | 11,645 | - | - | Indirect |
| Jun 24, 2024 | CELC Celcuity Inc. | Gift(G) Stock Option (right to buy) | 16,300 | - | - | Indirect |
| Jun 24, 2024 | CELC Celcuity Inc. | Gift(G) Stock Option (right to buy) | 16,300 | - | - | Direct |
1-18 of 18 transactions
About Murphy Polly A.
Murphy Polly A. (SEC CIK 0001829248) files insider reports with the SEC as Director of Atea Pharmaceuticals, Inc. (AVIR) and Director of Celcuity Inc. (CELC).
Signal8 holds 8 ownership filings by Murphy Polly A., all Form 4s, filed between May 21, 2025 and Jun 23, 2026. Those filings report 18 transactions, from Jun 24, 2024 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Murphy Polly A.'s filings is in MINNEAPOLIS, MN.
Recent filings by Murphy Polly A.
- Jun 18, 2026: Grants or awards of AVIR derivative securities (2 lines, Form 4, code A).
- Jun 18, 2026: Option exercise of AVIR shares (Form 4, code M).
- Jun 10, 2026: Gifts of CELC derivative securities (2 lines, Form 4, code G).
- Jun 5, 2026: Grant or award of CELC shares (Form 4, code A).
- May 18, 2026: Open-market purchase of AVIR shares (Form 4, code P).
Other insiders filing for Atea Pharmaceuticals, Inc. (AVIR)
- Lucidi Bruno, Director
- BERGER FRANKLIN M, Director
- Berman Howard, Director
- DUNCAN BARBARA GAYLE, Director
- Polsky Bruce, Director
- Adams Jerome M., Director